Page last updated: 2024-10-31

naphazoline and Dysarthosis

naphazoline has been researched along with Dysarthosis in 1 studies

Naphazoline: An adrenergic vasoconstrictor agent used as a decongestant.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Stipancic, KL1
van Brenk, F1
Kain, A1
Wilding, G1
Tjaden, K1

Other Studies

1 other study available for naphazoline and Dysarthosis

ArticleYear
Clear Speech Variants: An Investigation of Intelligibility and Speaker Effort in Speakers With Parkinson's Disease.
    American journal of speech-language pathology, 2022, 11-16, Volume: 31, Issue:6

    Topics: Dysarthria; Hearing Loss; Humans; Naphazoline; Parkinson Disease; Speech Acoustics; Speech Intelligi

2022